Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The major goal of this project is to investigate established insomnia treatments in a
schizophrenia population to see if the improved sleep leads to overall better quality of
life. In addition, we hypothesize that the insomnia treatment may also lead to observed
improvements in other symptoms associated with schizophrenia such as cognitive impairments,
obesity, and negative symptoms.